{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0016049",
      "entity_text" : "cell growth",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:5350",
      "entity_text" : "sulforaphane",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Accordingly, we explored whether a low dose of the antioxidant sulforaphane (SFN) in combination with the epigenetic drug 5-aza-2 '-deoxycytidine (DAC) could slow melanoma cell growth.",
  "reading_complete" : "2020-08-05T20:14:45Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T20:09:46Z",
  "trigger" : "slow",
  "evidence" : [ "sulforaphane (SFN) in combination with the epigenetic drug 5-aza-2'-deoxycytidine (DAC) could slow melanoma cell growth" ],
  "pmc_id" : "6789461",
  "score" : 0
}